About imiquimod
Immune response modifier
Used for
- External genital and perianal warts
- Actinic keratosis on the face or scalp
- Superficial basal cell carcinoma in suitable adults
Usual adult dose
Warts: apply 3 times weekly until cleared, up to 16 weeks. Actinic keratosis: apply twice weekly for 16 weeks. Basal cell carcinoma: apply 5 times weekly for 6 weeks.
Common side effects
- Redness, swelling, scaling, or sores where applied
- Burning, itching, or tenderness at the application site
- Headache or flu-like symptoms
- Skin color changes or scarring
Important warnings
- Use only on prescribed skin areas; avoid eyes, mouth, and vagina.
- Severe skin reactions can occur; treatment breaks may be needed.
- Avoid sexual contact while cream is on; it may weaken condoms and diaphragms.
- Not for internal genital, urethral, or anal lesions.
Pregnancy
Human pregnancy data are limited; use only when clearly needed after clinician assessment.
Breastfeeding
It is unknown whether imiquimod passes into breast milk; avoid infant contact with treated skin.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.